External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home EASL International Liver Congress 2020
Roche and Genentech at

EASL International Liver Congress 2020

August 27 - August 29
London, United Kingdom
ilc-congress.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
03:45 PM
Duration 15mins Virtual
Atezolizumab▼ + bevacizumab▼ versus sorafenib in patients with unresectable hepatocellular carcinoma: safety results from the Phase III IMbrave150 study
Ducreux M
Oncology | Gastrointestinal Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.